Dachaigh › Carcinoma Neuroendocrine › Missouri

Sgrùdaidhean clionaigeach Carcinoma Neuroendocrine ann an Missouri

Tha 3 sgrùdaidhean airson Carcinoma Neuroendocrine a’ lorg phàirtichean aig làraichean ann an Missouri.

Bailtean ann an Missouri

St. Louis3 sgrùdaidhean

Teacsa sgrùdaidh oifigeil (Beurla)

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Washington University Medicine, St Louis

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT07488923

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Washington University School of Medicine (Siteman Cancer Center), St Louis

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Iuch 2026 · NCT05652686

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Washington University Infusion Center Pharmacy, St Louis

A’ fastadhÌre 1/2

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT03093116

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.